$BDX News

Becton Dickinson (BDX) Could Be 1% Overvalued As PREVENT Trial Enrollment Ends

Becton Dickinson (BDX) Stock Could Be A Bargain On Cash Flow But Full On Broader Checks

Becton Dickinson (BDX) Completes PREVENT Trial Enrollment For Hernia Prevention Mesh

What's Going On With Becton Dickinson Stock Wednesday?

FDA Issues Early Alert For High-Risk Issue With Becton Dickinson Convenience Kits; Becton Dickinson Advises Removal Of Recalled Components From Convenience Kits; Warns Against Use Of Sodium Chloride Ampules In Affected Bd Kits

BD Appoints Gary Sorsher as Chief Quality Officer; Jeff Silvestri to Retire

Are Wall Street Analysts Predicting Becton, Dickinson and Company Stock Will Climb or Sink?

Becton Dickinson: An Earnings Beat Again As Diverse Clinical Portfolio Keeps On Growing

RBC Capital Maintains Sector Perform on Becton Dickinson, Raises Price Target to $190

BD Accelerates Advanced Tissue Regeneration Strategy with Landmark PREVENT Trial

Becton, Dickinson And Co. Completes Enrollment In PREVENT Clinical Trial Evaluating Phasix Mesh For Prevention Of Incisional Hernias

Jim Cramer Sees Cheap Valuation in Becton, Dickinson (BDX) After Q3 Beat and Raised Guidance

Becton Dickinson (BDX) Stock Sees Modest Fair Value Lift After Mixed Analyst Views

Why Becton Dickinson (BDX) Is Up 6.8% After Q3 Beat And GLP-1 Delivery Partnerships

Becton Dickinson & Co (BDX) (Q3 2026) Earnings Call Highlights: Strong Revenue Growth and ...

Becton, Dickinson and Company Q3 Earnings Call Highlights

Citigroup Maintains Buy on Becton Dickinson, Raises Price Target to $204

RBC Capital Maintains Sector Perform on Becton Dickinson, Raises Price Target to $180

Piper Sandler Maintains Neutral on Becton Dickinson, Raises Price Target to $175

Wells Fargo Maintains Equal-Weight on Becton Dickinson, Raises Price Target to $170